Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 22.9 CHF 2.69% Market Closed
Market Cap: 457.1m CHF

Wall Street
Price Targets

NWRN Price Targets Summary
Newron Pharmaceuticals SpA

Wall Street analysts forecast NWRN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NWRN is 18.62 CHF with a low forecast of 11.62 CHF and a high forecast of 26.25 CHF.

Lowest
Price Target
11.62 CHF
49% Downside
Average
Price Target
18.62 CHF
19% Downside
Highest
Price Target
26.25 CHF
15% Upside
Newron Pharmaceuticals SpA Competitors:
Price Targets
REC
Recordati Industria Chimica e Farmaceutica SpA
27% Upside
IRD
Opus Genetics Inc
291% Upside
ETON
Eton Pharmaceuticals Inc
87% Upside
FAE
Faes Farma SA
8% Upside
MRK
Merck KGaA
21% Upside

Revenue
Forecast

Revenue Estimate
Newron Pharmaceuticals SpA

For the last 13 years the compound annual growth rate for Newron Pharmaceuticals SpA's revenue is 49%. The projected CAGR for the next 4 years is 38%.

49%
Past Growth
38%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Newron Pharmaceuticals SpA

The compound annual growth rate of Newron Pharmaceuticals SpA's operating income for the next 4 years is 55%.

N/A
Past Growth
55%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Newron Pharmaceuticals SpA

The compound annual growth rate of Newron Pharmaceuticals SpA's net income for the next 4 years is 57%.

N/A
Past Growth
57%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NWRN's stock price target?
Price Target
18.62 CHF

According to Wall Street analysts, the average 1-year price target for NWRN is 18.62 CHF with a low forecast of 11.62 CHF and a high forecast of 26.25 CHF.

What is Newron Pharmaceuticals SpA's Revenue forecast?
Projected CAGR
38%

For the last 13 years the compound annual growth rate for Newron Pharmaceuticals SpA's revenue is 49%. The projected CAGR for the next 4 years is 38%.

What is Newron Pharmaceuticals SpA's Operating Income forecast?
Projected CAGR
55%

The compound annual growth rate of Newron Pharmaceuticals SpA's operating income for the next 4 years is 55%.

What is Newron Pharmaceuticals SpA's Net Income forecast?
Projected CAGR
57%

The compound annual growth rate of Newron Pharmaceuticals SpA's net income for the next 4 years is 57%.

Back to Top